NCT05132270View on ClinicalTrials.gov

Clinical Experience of Thalidomide in Thalassemic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

January 31, 2021

Conditions
Thalassemia, Beta
Interventions
DRUG

hydroxyurea and thalidomide

Evaluation of hydroxyurea and thalidomide combination use in beta-thalassemia patients

Trial Locations (1)

Unknown

Children's Hospital Karachi, Karachi

All Listed Sponsors
lead

Children's Hospital Karachi

OTHER

NCT05132270 - Clinical Experience of Thalidomide in Thalassemic Patients | Biotech Hunter | Biotech Hunter